» Articles » PMID: 31853228

Exosomal MicroRNA-155 Inhibits Enterovirus A71 Infection by Targeting PICALM

Overview
Journal Int J Biol Sci
Specialty Biology
Date 2019 Dec 20
PMID 31853228
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Enterovirus A71 (EV-A71) causes hand, foot, and mouth disease (HFMD) that is associated with neurological complications. Researchers have shown that exosomes containing host cellular microRNA (miRNA) can modulate the recipient's cellular response during viral infection. However, it is unclear how exosomal miRNAs regulate this response during EV-A71 infection. In this study, we used an exosomal miRNA chip to show that microRNA-155 (miR-155) was markedly enriched in exosomes after EV-A71 infection. Moreover, exosomal miR-155 efficaciously inhibited EV-A71 infection by targeting phosphatidylinositol clathrin assembly protein (PICALM) in recipient cells. Importantly, we confirmed that exosomal miR-155 reduced EV-A71 infection severity . Additionally, miR-155 levels in throat swabs from EV-A71-infected patients were higher than in those from healthy individuals. Collectively, our findings provide evidence that exosomal miR-155 plays a role in host-pathogen interactions by mediating EV-A71 infection via the repression of PICALM; these results provide insights into the regulatory mechanisms of viral infection.

Citing Articles

Exosomes in Oral Diseases: Mechanisms and Therapeutic Applications.

Miao Q, Li S, Lyu W, Zhang J, Han Y Drug Des Devel Ther. 2025; 19:457-469.

PMID: 39867866 PMC: 11766710. DOI: 10.2147/DDDT.S505355.


Picalm, a novel regulator of GLUT4-trafficking in adipose tissue.

Gaugel J, Haacke N, Sehgal R, Jahnert M, Jonas W, Hoffmann A Mol Metab. 2024; 88:102014.

PMID: 39182843 PMC: 11402323. DOI: 10.1016/j.molmet.2024.102014.


An HIV-1 CRISPR-Cas9 membrane trafficking screen reveals a role for PICALM intersecting endolysosomes and immunity.

Guizar P, Abdalla A, Monette A, Davis K, Caballero R, Niu M iScience. 2024; 27(6):110131.

PMID: 38957789 PMC: 11217618. DOI: 10.1016/j.isci.2024.110131.


Emerging roles of exosomes in oral diseases progression.

Wang J, Jing J, Zhou C, Fan Y Int J Oral Sci. 2024; 16(1):4.

PMID: 38221571 PMC: 10788352. DOI: 10.1038/s41368-023-00274-9.


infection upregulates and engages host macrophage Argonaute 1, and system-wide proteomics reveals Argonaute 1-dependent host response.

Moradimotlagh A, Chen S, Koohbor S, Moon K, Foster L, Reiner N Front Immunol. 2023; 14:1287539.

PMID: 38098491 PMC: 10720368. DOI: 10.3389/fimmu.2023.1287539.


References
1.
Mourelatos Z, Dostie J, Paushkin S, Sharma A, Charroux B, Abel L . miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 2002; 16(6):720-8. PMC: 155365. DOI: 10.1101/gad.974702. View

2.
Ahluwalia J, Khan S, Soni K, Rawat P, Gupta A, Hariharan M . Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology. 2008; 5:117. PMC: 2635386. DOI: 10.1186/1742-4690-5-117. View

3.
Longatti A, Boyd B, Chisari F . Virion-independent transfer of replication-competent hepatitis C virus RNA between permissive cells. J Virol. 2014; 89(5):2956-61. PMC: 4325714. DOI: 10.1128/JVI.02721-14. View

4.
Friedman R, Farh K, Burge C, Bartel D . Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2008; 19(1):92-105. PMC: 2612969. DOI: 10.1101/gr.082701.108. View

5.
Mercer J, Schelhaas M, Helenius A . Virus entry by endocytosis. Annu Rev Biochem. 2010; 79:803-33. DOI: 10.1146/annurev-biochem-060208-104626. View